August 15, 2019
Announcement no. 16

BioPorto A/S - Extraordinary General Meeting
Today, BioPorto A/S held an extraordinary general meeting where Christopher Lindop and Michael Singer were elected as members of the Board of Directors. There were no other changes to the composition of the Board of Directors.

Hellerup, August 15, 2019
BioPorto A/S
The Board of Directors

For further information, please contact:
Peter Mørch Eriksen, CEO
Ole Larsen, CFO
Telephone +45 4529 0000, e-mail investor@bioporto.com

About BioPorto

BioPorto is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. BioPorto has its headquarters in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange

 

Attachment